Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM.

Hypertension. 2008 Jun;51(6):1403-19. doi: 10.1161/HYPERTENSIONAHA.108.189141. Epub 2008 Apr 7.

2.

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM; American Heart Association Professional Education Committee.

Circulation. 2008 Jun 24;117(25):e510-26. doi: 10.1161/CIRCULATIONAHA.108.189141.

3.

Resistant hypertension - an update.

Pasha K, Towhiduzzaman M, Manwar A, Jahan MU.

Mymensingh Med J. 2015 Apr;24(2):434-43.

PMID:
26007281
4.

Resistant hypertension in the elderly.

Rafey MA.

Clin Geriatr Med. 2009 May;25(2):289-301. doi: 10.1016/j.cger.2009.01.006.

PMID:
19555873
5.

Characterization and treatment of resistant hypertension.

Pisoni R, Ahmed MI, Calhoun DA.

Curr Cardiol Rep. 2009 Nov;11(6):407-13. Review.

6.

Treatment of resistant hypertension.

Czarina Acelajado M, Calhoun DA.

Minerva Cardioangiol. 2009 Dec;57(6):787-812. Review.

PMID:
19942848
7.

[Resistant hypertension: evaluation and treatment].

Girerd X, Rosenbaum D, Villeneuve F.

Presse Med. 2009 Apr;38(4):643-51. doi: 10.1016/j.lpm.2009.02.004. Epub 2009 Mar 17. Review. French.

PMID:
19297124
8.

Resistant hypertension: an overview of evaluation and treatment.

Sarafidis PA, Bakris GL.

J Am Coll Cardiol. 2008 Nov 25;52(22):1749-57. doi: 10.1016/j.jacc.2008.08.036. Review.

9.

Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, Amodeo C, Bortolotto LA, Krieger EM, Bradley TD, Lorenzi-Filho G.

Hypertension. 2011 Nov;58(5):811-7. doi: 10.1161/HYPERTENSIONAHA.111.179788. Epub 2011 Oct 3.

10.

Resistant or difficult-to-treat hypertension.

Calhoun DA.

J Clin Hypertens (Greenwich). 2006 Mar;8(3):181-6. Review.

11.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

12.

Update on diagnosis and treatment of resistant hypertension.

Pimenta E.

Iran J Kidney Dis. 2011 Jul;5(4):215-27. Review.

13.

The prevalence, incidence, prognosis, and associated conditions of resistant hypertension.

Vega J, Bisognano JD.

Semin Nephrol. 2014 May;34(3):247-56. doi: 10.1016/j.semnephrol.2014.04.002. Epub 2014 Apr 18. Review.

PMID:
25016397
14.

The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.

Hemmelgarn BR, Zarnke KB, Campbell NR, Feldman RD, McKay DW, McAlister FA, Khan N, Schiffrin EL, Myers MG, Bolli P, Honos G, Lebel M, Levine M, Padwal R; Canadian Hypertension Education Program, Evidence-Based Recommendations Task Force.

Can J Cardiol. 2004 Jan;20(1):31-40.

PMID:
14968141
15.

Resistant Hypertension.

Doroszko A, Janus A, Szahidewicz-Krupska E, Mazur G, Derkacz A.

Adv Clin Exp Med. 2016 Jan-Feb;25(1):173-83. doi: 10.17219/acem/58998. Review.

16.

ESH-ESC guidelines for the management of hypertension.

Erdine S, Ari O, Zanchetti A, Cifkova R, Fagard R, Kjeldsen S, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, Staessen J, van Zwieten P, Waeber B, Williams B.

Herz. 2006 Jun;31(4):331-8.

PMID:
16810473
17.

The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification.

Zarnke KB, McAlister FA, Campbell NR, Levine M, Schiffrin EL, Grover S, McKay DW, Myers MG, Wilson TW, Rabkin SW, Feldman RD, Burgess E, Bolli P, Honos G, Lebel M, Mann K, Abbott C, Tobe S, Petrella R, Touyz RM; Canadian Hypertension Recommendations Working Group.

Can J Cardiol. 2002 Jun;18(6):604-24.

PMID:
12107419
18.

[Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension].

Waeber B, Feihl F.

Rev Med Suisse. 2012 Jan 11;8(323):28-30. French.

PMID:
22303736
19.

Secondary hypertension, issues in diagnosis and treatment.

Pullalarevu R, Akbar G, Teehan G.

Prim Care. 2014 Dec;41(4):749-64. doi: 10.1016/j.pop.2014.08.001. Epub 2014 Oct 7.

PMID:
25439532
20.

Current options for the treatment of resistant hypertension.

Ahmed MI, Pisoni R, Calhoun DA.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1385-93. doi: 10.1586/erc.09.120. Review.

PMID:
19900021

Supplemental Content

Support Center